TCG Crossover Management, LLC
PALO ALTO, CA · CIK 1839948 · 13F filing filed 2022-08-15
No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.
- Others nearbyPalo Alto, CA
$235.4m
reported value
-5.5% vs Q1 2022
22positions
80.2%in top 10
2 new
4 added
4 reduced
0 sold out
vs Q1 2022
Holdings, Q2 2022
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| COGENT BIOSCIENCES INC COGT | $31.4m13.34% | Added +500.0k |
| IVERIC BIO INC OPHT | $28.0m11.91% | Added +397.3k |
| GERON CORP GERN | $23.4m9.94% | Added +810.6k |
| KURA ONCOLOGY INC KURA | $21.4m9.09% | Added +661.2k |
| CYMABAY THERAPEUTICS INC CBAY | $17.4m7.40% | Unchanged |
| ACLARIS THERAPEUTICS INC ACRS | $16.0m6.79% | Unchanged |
| VIRIDIAN THERAPEUTICS INC VRDN | $15.2m6.46% | Unchanged |
| CHINOOK THERAPEUTICS INC ADRO | $13.9m5.92% | Reduced -85.9k |
| AEROVATE THERAPEUTICS INC COM | $13.9m5.91% | Unchanged |
| ENTRADA THERAPEUTICS INC TRDA | $8.1m3.43% | Unchanged |
| MERUS N V MRUS | $6.8m2.89% | Unchanged |
| TYRA BIOSCIENCES INC TYRA | $6.4m2.72% | Unchanged |
| AKOUOS INC COM | $6.3m2.69% | Unchanged |
| TANGO THERAPEUTICS INC TNGX | $5.3m2.26% | Reduced -82.2k |
| MOONLAKE IMMUNOTHERAPEUTICS MLTX | $5.2m2.23% | New |
| ALPINE IMMUNE SCIENCES INC NVLS | $4.9m2.09% | Reduced -456.0k |
| 89BIO INC ETNB | $3.6m1.55% | New |
| ZAI LAB LTD ZLAB | $3.3m1.40% | Unchanged |
| MAGENTA THERAPEUTICS INC COM | $2.5m1.08% | Unchanged |
| ANAPTYSBIO INC ANAB | $1.2m0.50% | Unchanged |
| ELEVATION ONCOLOGY INC COM | $777.0k0.33% | Unchanged |
| PARDES BIOSCIENCES INC COM | $181.0k0.08% | Reduced -170.1k |